Aniara | Shaping the Future with Innovative Solutions
 
 Search
 

Learning Center

Hemostasis Happenings


Friday, September 3, 2010

HEMOSTASIS HAPPENINGS: SEPTEMBER 2010

WHAT’S HAPPENING:  SEPTEMBER 2010

NEW FORMAT:  CONFERENCES WILL BE POSTED A MONTH AHEAD, SO YOU HAVE TIME TO INQUIRE- INSTEAD OF THE PRESENT MONTH. 

 

UPDATE ON THE MANAGEMENT

OF THROMBOEMBOLIC DISORDERS

Monday-Wednesday

October 11-13, 2010

The Meritage

Napa, California 

 

MONDAY, OCTOBER 11

7:00 am Registration, continental breakfast, visit exhibits

8:00 Welcome and Review of Objectives

Richard White, MD

8:05 Epidemiology of Venous Thromboembolism:

Clinical Implications

Richard White, MD

8:35 The Down Side of Venous Thromboembolism:

Bleeding, Post Thrombotic Syndrome, and Chronic

Pulmonary Hypertension

Susan Murin, MD, MSc

9:05 Case Presentations: Ultrasound Screening,

Ultrasound Testing After Treatment of DVT

9:25 Panel Q&A

Moderator: William Geerts, MD

9:45 Break, visit exhibits

10:00 Cancer and Thrombosis: Clinical Implications

Theodore Wun, MD

10:30 Prevention of VTE:

Making It Evidence-Based and Simple

William Geerts, MD

11:00 Case Presentations: Upper Extremity DVT,

Superficial, Bridging, Lower Extremity Injury

11:20 Panel Q&A

Moderator: Richard White, MD

11:40 Lunch (included in tuition)EBATE SESSION

hould We Look for Calf Vein Thrombosis?

12:45 pm Diagnosis of DVT/PE: What Steps and in What Order?

Richard White, MD

1:05 Pro: Yes, Calf Vein DVT Is Important

Susan Murin, MD, MSc

1:20 Con: No, Anticoagulation Is Dangerous

Richard White, MD

1:35 Rebuttal: Pro

1:40 Rebuttal: Con

1:45 Q&A

2:05 Adjourn

RECEPTION

4:30 pm Estate Wine Cave Reception

Pre-registration required – see enrollment form.

Complimentary for course participants, fee for guests.

Meet the faculty, course participants and guests as you

enjoy light appetizers and live music while experiencing

wines from Trinitas Cellars of Napa.

Case Based Workshop

7:00 pm Management of an Anticoagulation Program

Jennifer Branch, PharmD

William Dager, PharmD

8:15 Adjourn

TUESDAY, OCTOBER 12

7:00 am Continental breakfast, visit exhibits

7:00 “Meet the Professor” Breakfast Roundtables

Informal discussion with faculty, limited seating,

pre-registration not required

1. PE/DVT Prediction Tools Dr. White

2. VTE Prophylaxis Dr. Geerts

3. Cancer and VTE Issues Dr. Wun

4. Pulmonary Embolism Dr. Murin

5. Dosing/Monitoring Anticoagulants Dr. Dager

8:05 Regulatory Oversight of Anticoagulation/

Patient Safety

John Grubbs, MS, MBA, RPh

8:35 Thromboprophylaxis:

Which Drugs? Pumps? Timing? Duration?

William Geerts, MD

9:05 Case Presentations:

Regulatory Issues, Implementing Prophylaxis,

Dilemmas

9:25 Panel Q&A

Moderator: William Dager, PharmD

9:45 Break, visit exhibits

10:00 Anticoagulating Our Special Patients

William Dager, PharmD

10:30 New Anticoagulants in Development

Alexandra Grubbs, PharmD

11:00 Case Presentations:

Special Cases and Cancer Cases

11:25 Panel Q&A

Moderator: William Geerts, MD

11:45 Lunch (included in tuition)CIAL DEBATE SESSION

Treatment of Heparin-Induced Thrombocytopenia

(IT): Should we use Anti-Xa or Anti-IIa?

12:45 pm Update on Diagnosis and Management of HIT

Theodore Wun, MD

1:05 Pro: Use Anti-Xa Inhibitors

Theodore Wun, MD

1:20 Con: Use Anti-IIa Inhibitors

William Dager, PharmD

1:35 Rebuttal: Pro

1:40 Rebuttal: Con

1:45 Q&A

2:05 Adjourn

Case Based Workshop

7:00 pm Improving the Quality of Inpatient Anticoagulant

Care: What Can Be Done?

Health-care System Perspective Susan Murin, MD

Pharmacist Perspective William Dager, PharmD

Physician Perspective Richard White, MD

8:15 Adjourn

WEDNESDAY, OCTOBER 13

7:00 am Continental breakfast, visit exhibits

7:00 “Meet the Professor” Breakfast Roundtables

Informal discussion with faculty, limited seating,

pre-registration not required

6. Being a Champion in

Your Institution Dr. White

7. Using the ACCP Guidelines

in Practice Dr. Geerts

8. Hypercoagulable Testing Dr. Wun

9. ICU Considerations Dr. Murin

10. Anticoagulation Management

in Difficult Patients Dr. Dager

8:05 Reversing Anticoagulants: The Plot Thickens

William Dager, PharmD

8:35 Use of Inferior Vena Cava (IVC) Filters:

When Are They Appropriate? Do They Help?

William Geerts, MD

9:05 Case Presentations:

Filter Issues, Difficult Cases

9:25 Panel Q&A

Moderator: Richard White, MD

9:45 Break, visit exhibits

10:00 Deciding How Long to Anticoagulate VTE Patients

Richard White, MD

10:30 Chest Guidelines: What They Say and Don’t Say

Susan Murin, MD, MSc

11:00 Case Presentations: Thrombophilia,

Anti-phospholipid Antibody Syndrome (APS)

11:20 Panel Q&A

Moderator: William Geerts, MD

11:40 Adjourn, turn in evaluation, pick up certificate of

attendance

FAC ULTY

COURSE CO-CHAIR S

GUEST SPEA KER S

CONFERE NCE COORDINAT OR

Cheryl Nelson

Accreditation Manager

Office of Continuing Medical Education

University of California, Davis

The 33rd World Congress of the International Society of Hematology

- Date : October 10 - 13, 2010
- Place : Jerusalem - Israel

- Site : www.kenes.com/ISH2010

APSTH (56th Congress of the Asia Pacific Society on Thrombosis and Haemostasis)

- Date : October 13 - 16, 2010
- Place : Bali - Indonesia

- Site : http://www.apsth2010bali.com

ASCP ANNUAL MEETING

- October 27-31, 2010
- San Francisco Marriot Marquis

5737 An Overview of Hemostasis

Thursday, October 28 9:30 am - 11:30 am

This in-depth course will provide an overview and update of hemostasis, including coverage of coagulation and fibrinolysis testing, as well as a brief review of laboratory evaluation of the most common thrombophilic risk factors. Case studies will be used to demonstrate many of the assays and concepts. Discussions will include frequently ordered hemostasis assays, laboratory evaluation for lupus anticoagulants, and much more. You will leave with the ability to:

Identify hemostasis assays that should be performed in patients with a bleeding diathesis but normal APTT and PT assays and interpret the results.
Implement evaluation of an abnormal APTT and/or PT.
Identify the assays commonly performed to evaluate for thrombophilia.
Recognize the clinical utility of certain assays used to evaluate for the presence of a lupus anticoagulant.

Moderator:
Dorothy M. Adcock-Funk, MD, FASCP, Esoterix

A259 Anticoagulation Therapy Optimizing Patient Safety

Saturday, October 30 3:45 pm - 5:00 pm

Get an overview of the laboratory monitoring of both established and new anticoagulants and antiplatelet drugs. You will learn about identifying commonly misordered tests, tests that are affected by the draw times, the ways in which pharmacogenetics can optimize dosing and identify poor metabolizers, and ways to improve laboratory reports. You will leave with the ability to:

Discuss the pharmacology and laboratory monitoring of both established and newer anticoagulant and antiplatelet medications.
Recognize the ways in which pharmacogenetics optimize dosing or identify poor-metabolizers.
Identify ways in which the laboratory can improve the safety of patients on anticoagulant therapy.

Moderator:
Jeffrey S. Dlott, MD, FASCP, Quest Diagnostics Nichols Institute

Credits: 1.25 CME
HEME, TM
SAMs

IX Argentine Congress on Haemostasis and Thrombosis - CAHT 2010
28-30 October 2010, Buenos Aires, Argentina.
The Congress is organised by the Haemostasis and Thrombosis Cooperative Group of Argentina (Grupo CAHT) chaired by Alicia Blanco PhD. Deadline for abstract submissions: 11th July 2010. For more information, on-line registration and abstract submission, please visit

Site : www.grupocaht.com/congreso2010

 

Donna Castellone

Bookmark and Share

 

About the Author

Donna Castellone,  MS, MT(ASCP)SH

Donna Castellone,
MS, MT(ASCP)SH

View Complete Profile


Links


Previous Posts


Archives

RSS Feed

 
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
Aniara